J. Goldman & Co’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,750
| Closed | -$165K | – | 297 |
|
|
2024
Q1 | $165K | Sell |
22,750
-407,066
| -95% | -$2.95M | 0.01% | 255 |
|
|
2023
Q4 | $2.15M | Sell |
429,816
-65,519
| -13% | -$328K | 0.09% | 117 |
|
|
2023
Q3 | $2.09M | Sell |
495,335
-2,709
| -0.5% | -$11.4K | 0.07% | 133 |
|
|
2023
Q2 | $2.01M | Buy |
+498,044
| New | +$2.01M | 0.07% | 135 |
|
|
2018
Q2 | – | Sell |
-5,907
| Closed | -$2.12M | – | 229 |
|
|
2018
Q1 | $2.12M | Sell |
5,907
-364
| -6% | -$131K | 0.09% | 132 |
|
|
2017
Q4 | $2.49M | Buy |
6,271
+5,343
| +576% | +$2.12M | 0.13% | 103 |
|
|
2017
Q3 | $396K | Sell |
928
-11,272
| -92% | -$4.81M | 0.02% | 166 |
|
|
2017
Q2 | $1.95M | Buy |
12,200
+824
| +7% | +$132K | 0.11% | 105 |
|
|
2017
Q1 | $1.42M | Buy |
+11,376
| New | +$1.42M | 0.07% | 135 |
|